Trials / Completed
CompletedNCT00755066
Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE
The Effect of Intranasal Corticosteroid on the Immune Response Following Nasal Allergen Challenge in Patients Suffering From Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effect of fluticasone propionate vs placebo applied as nasal spray on the increase of allergen-specific serum IgE levels following nasal exposure to recombinant allergens. Nasal sprays will be applied for four weeks starting two weeks before nasal provocation and serum IgE levels will be followed during eight weeks after nasal provocation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone propionate | 200 µg intranasal, 4 weeks, od. |
| DRUG | Placebo | Placebo intranasal spray |
Timeline
- First posted
- 2008-09-18
- Last updated
- 2008-09-26
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00755066. Inclusion in this directory is not an endorsement.